Controllability in cancer metabolic networks according to drug targets as driver nodes

Area of Science:

• Systems Biology
• Network Science
• Computational Biology

Background:

• Biological networks are widely studied for structure-function relationships.
• Dynamic and control features of complex networks remain under-researched compared to topology.
• Network medicine aims to identify drug targets within biological networks.

Purpose of the Study:

• To explore the relationship between network controllability, topological parameters, and metabolic drug targets in cancer.
• To investigate if topological network features can predict or explain drug target roles.

Main Methods:

• Applied topological analysis to genome-scale metabolic models of normal and cancer cell types.
• Assumed approved anticancer metabolic drug targets represent driver nodes controlling cancer networks.
• Analyzed network parameters, including motifs and clusters, in relation to controllability.

Main Results:

• Complex network metrics like motifs and clusters are relevant for system control.
• A controllability relationship exists between topological parameters and drug targets.
• Driver nodes controlling cancer metabolic networks can be identified within network clusters.

Conclusions:

• Network clusters, rather than individual nodes, may be key for controlling cancer metabolic networks.
• Distributed control systems offer a new strategy for network medicine.
• This approach could refine the identification of metabolic drug targets for cancer therapy.